Mirjam Sprangers
Overview
Explore the profile of Mirjam Sprangers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
565
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bjelic-Radisic V, Cardoso F, Weis J, Pogoda K, Arraras J, Greimel E, et al.
Breast
. 2025 Feb;
80:103890.
PMID: 39947087
Background: The EORTC QLQ-BR23, published in 1996, was one of the first disease-specific questionnaires to assess health-related quality of life (HRQoL) in patients with breast cancer (BC). In the last...
2.
Dekker J, Doppenberg-Smit E, Braamse A, Lamers F, van Linde M, Verheul H, et al.
Front Psychiatry
. 2024 Apr;
15:1352026.
PMID: 38600981
Cancer and its associated treatment is a major stressor, leading to emotions such as anxiety or depressive mood. Human emotions have developed through the course of evolution because they facilitate...
3.
Kamp A, Bood Z, Scherer-Rath M, Weeseman Y, Christophe N, Dorr H, et al.
J Cancer Surviv
. 2021 Jun;
16(3):531-541.
PMID: 34129212
Purpose: Patients with advanced cancer can experience their disease as a contingent life event. The sudden interruption of their life stories can obscure life goals and disrupt meaning making. In...
4.
Vanier A, Oort F, McClimans L, Ow N, Gulek B, Bohnke J, et al.
Qual Life Res
. 2021 May;
30(12):3323-3324.
PMID: 34043133
No abstract available.
5.
Vanier A, Oort F, McClimans L, Ow N, Gulek B, Bohnke J, et al.
Qual Life Res
. 2021 Apr;
30(12):3309-3322.
PMID: 33909187
Purpose: The extant response shift definitions and theoretical response shift models, while helpful, also introduce predicaments and theoretical debates continue. To address these predicaments and stimulate empirical research, we propose...
6.
Ngowi K, Pima F, Mmbaga B, Aarnoutse R, Reiss P, Nieuwkerk P, et al.
Patient Prefer Adherence
. 2021 Mar;
15:559-568.
PMID: 33727801
Introduction: Digital Adherence Tools (DAT) to promote adherence to antiretroviral treatment (ART) for HIV are being increasingly adopted globally, however their effectiveness and acceptability in limited resource settings has been...
7.
Sodergren S, Wheelwright S, Fitzsimmons D, Efficace F, Sprangers M, Fayers P, et al.
Target Oncol
. 2020 Nov;
16(1):95-107.
PMID: 33165751
Background: Targeted therapies (TTs) have revolutionised cancer treatment with their enhanced specificity of action. Compared with conventional therapies, TTs are delivered over a longer period and often have unusual symptom...
8.
Giesinger J, Blazeby J, Aaronson N, Sprangers M, Fayers P, Sparano F, et al.
Value Health
. 2020 May;
23(5):666-673.
PMID: 32389233
Objectives: Patient-reported outcome (PRO) measurements used in cancer research can assess a number of health domains. Our primary objective was to investigate which broad types of PRO domains (namely, functional...
9.
Van Hemelrijck M, Sparano F, Moris L, Beyer K, Cottone F, Sprangers M, et al.
Cancer Med
. 2020 Apr;
9(12):4039-4058.
PMID: 32333639
Background: Given the growing importance of patient-reported outcomes (PROs) as part of "big data" in improving patient care, there is a need to provide a state-of-the-art picture of the added...
10.
Van Hemelrijck M, Sparano F, Josephs D, Sprangers M, Cottone F, Efficace F
BMC Urol
. 2019 Sep;
19(1):86.
PMID: 31521149
Background: Despite international recommendations of including patient-reported outcomes (PROs) in randomised clinical trials (RCTs), a 2014 review concluded that few RCTs of bladder cancer (BC) report PRO as an outcome....